HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Drug shortages threaten patient health and safety
-
- ATTRACT-1: ASA404 failed to improve outcomes in advanced NSCLC
- Brentuximab vedotin wins accelerated approval for HL, anaplastic large cell lymphoma
- Calcium with vitamin D reduced melanoma risk by more than half in women at high risk
- Cancer incidence higher for men than women
- Certain patients with breast cancer at increased risk for MDS/AML
- Intervention by community health workers improved rates of screening mammography
- IV iron improved feeling of fatigue in premenopausal women with low serum ferritin concentration
- New model helped predict absolute risk for breast cancer in Italian population
-
- Number of palliative care teams more than doubled since 2000
- Cardio-oncology: A new focus for cardiovascular medicine W. Gregory Hundley, MD
- Young patient presents with prostate carcinoma and lesions on bone scan Munir Ghesani, MD, FACNM; Carlos Benitez, MD; Ronald Ennis, MD; Adi Friedman, MD; Sumit Talwar, MD
- ABCSG-12: Previous improvements in DFS with zoledronic acid in early breast cancer upheld
- Adding GnRH analogue to chemotherapy reduced early menopause in patients with breast cancer
- Elderly patients tolerated temozolomide for glioblastoma
- Lenalidomide associated with durable remissions in elderly patients with symptomatic CLL
- Results suggest that family histories should be updated every 5 to 10 years
-
- Texting program doubled smoking cessation Michael B. Steinberg, MD, MPH, FACP